/Investor DB

OCV Partners — 2024 Investments

4 investments dated 2024 · listed companies and verified rows first · show all

Mermaid Chartmermaidchart.comMar 2024 · $7.5M

Mermaid Chart offers an AI-assisted diagramming tool that turns plain-language prompts, uploaded files (such as PRDs, meeting transcripts, or schemas), and templates into structured diagrams like flowcharts, Gantt charts, mind maps, and system architecture diagrams.

AI & Machine LearningDeveloper ToolsSaaS

Co-investorsFirebrand VenturesGaingelsGood FriendsIrregular ExpressionsMana VenturesOpen Core Ventures+4 more

Orcaorcawater.lifeinMay 2024 · $23M

Orca Water builds a water monitoring and predictive leak detection system that uses ultrasonic sensors and machine learning to visualize and localize water use down to specific fixtures via an interactive dashboard.

AI & Machine LearningCleantechIoT

Co-investorsForesight CanadaInnovation UBCAnkona CapitalBrighton Park CapitalEnza CapitalMizMaa Ventures+2 more

Orcaorcainc.comin𝕏May 2024 · $23M

Orca is a software platform that modernizes venture capital fund management by automating operations and streamlining workflows.

Enterprise SoftwareFintechSaaS

Shalom(CEO and Founder)Itzik(Head of Growth)Artem(Chief Product Officer)Meital(CFO)

Co-investorsF2 Venture CapitalState of Mind VenturesAnkona CapitalBrighton Park CapitalEnza CapitalMizMaa Ventures+2 more

Torl Biotorlbio.comApr 2024

TORL BioTherapeutics develops antibody-drug conjugates (ADCs) targeting Claudin 6 (CLDN6) for the treatment of solid tumors such as ovarian, lung, endometrial, and testicular cancers.

BiotechHealthtechCulver City, US

Dave LicatainAran Maree M.D.inMark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)

PartnerChris Bostick· led

Co-investorsRA CapitalCowen Healthcare InvestmentsGoldman SachsPerceptive Xontogeny VentureVertex Ventures HC

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.